Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57,353
Closed -$259K 1638
2025
Q4
$259K Buy
+57,353
New +$294K 0.01% 1392

Y-Intercept (HK)'s CVAC Position: Q1 2026 in Review

Y-Intercept (HK) sold out of CureVac (CVAC) in Q1 2026, closing a stake of 57,353 shares — an estimated $259K sold.

Y-Intercept (HK) first reported a position in CVAC in Q4 2025 and held it in 1 quarter. The position peaked at $259K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Y-Intercept (HK) reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 57,353 CureVac shares in Q1 2026, an estimated $259K.
  • Y-Intercept (HK) first reported a position in CureVac in Q4 2025 and held it in 1 quarter.
  • Y-Intercept (HK)'s CureVac position peaked at $259K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.